Late cerebral relapse of a Mycobacterium avium complex disseminated infection in an HIV-infected patient after cessation of antiretroviral therapy

被引：2

作者：

Lascaux, AS ^{[1
]}

Lesprit, P

Deforges, L

Gutierrez, C

Lévy, Y

机构：

[1] Hop Henri Mondor, Serv Immunol Clin, F-94010 Creteil, France

[2] Hop Henri Mondor, Serv Bacteriol, F-94010 Creteil, France

[3] Inst Pasteur, CNRM, F-75015 Paris, France

来源：

AIDS | 2003年 / 17卷 / 09期

关键词：

D O I：

10.1097/00002030-200306130-00024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1410 / 1411

页数：2

共 9 条

[1] Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy [J].

Aberg, JA ;

Yajko, DN ;

Jacobson, MA .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) :1446-1449

[2] A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. [J].

de Quiros, JCLB ;

Miro, JM ;

Pena, JM ;

Podzamczer, D ;

Alberdi, JC ;

Martínez, E ;

Cosin, J ;

Claramonte, X ;

Gonzalez, J ;

Domingo, P ;

Casado, JL ;

Ribera, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :159-167

[3] Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy [J].

Guex, AC ;

Radziwill, AJ ;

Bucher, HC .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :602-603

[4] Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy [J].

Kirk, O ;

Reiss, P ;

Uberti-Foppa, C ;

Bickel, M ;

Gerstoft, J ;

Pradier, C ;

Wit, FW ;

Ledergerber, B ;

Lundgren, JD ;

Furrer, H ;

Seven European HIV Cohorts .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :239-250

[5]

Martínez E, 1999, AIDS, V13, P147

[6] Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection [J].

Murray R. ;

Mallal S. ;

Heath C. ;

French M. .

European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (3) :199-201

[7] Typing of Mycobacterium avium isolates by PCR [J].

Picardeau, M ;

Vincent, V .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) :389-392

[8] Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy [J].

Shafran, SD ;

Mashinter, LD ;

Phillips, P ;

Lalonde, RG ;

Gill, MJ ;

Walmsley, SL ;

Toma, E ;

Conway, B ;

Fong, IW ;

Rachlis, AR ;

Williams, KE ;

Garber, GE ;

Schlech, WF ;

Smaill, F .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (09) :734-737

[9] Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy [J].

Soriano, V ;

Dona, C ;

Rodríguez-Rosado, R ;

Barreiro, P ;

González-Lahoz, J .

AIDS, 2000, 14 (04) :383-386

← 1 →